Artificial intelligence-assisted repurposing of lubiprostone alleviates tubulointerstitial fibrosis
In this study, we investigated the antifibrotic effect of the machine learning-based repurposed drug, lubiprostone, validated through an advanced proximal tubule on a chip system and in vivo UUO mice model.
Source: Translational Research - Category: Research Authors: Anupama Samantasinghar, Faheem Ahmed, Chethikkattuveli Salih Abdul Rahim, Kyung Hwan Kim, Sejong Kim, Kyung Hyun Choi Source Type: research
More News: Chronic Kidney Disease | Clinical Trials | Kidney Transplant | Learning | Renal Failure | Research | Study | Universities & Medical Training | Urology & Nephrology